GHP Investment Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26K | Hold |
1,200
| – | – | ﹤0.01% | 593 |
|
|
2025
Q1 | $29.1K | Hold |
1,200
| – | – | ﹤0.01% | 558 |
|
|
2024
Q4 | $25K | Hold |
1,200
| – | – | ﹤0.01% | 572 |
|
|
2024
Q3 | $23.9K | Hold |
1,200
| – | – | ﹤0.01% | 597 |
|
|
2024
Q2 | $18.6K | Hold |
1,200
| – | – | ﹤0.01% | 606 |
|
|
2024
Q1 | $19.1K | Hold |
1,200
| – | – | ﹤0.01% | 594 |
|
|
2023
Q4 | $20.2K | Hold |
1,200
| – | – | ﹤0.01% | 572 |
|
|
2023
Q3 | $15.3K | Hold |
1,200
| – | – | ﹤0.01% | 641 |
|
|
2023
Q2 | $17.9K | Hold |
1,200
| – | – | ﹤0.01% | 601 |
|
|
2023
Q1 | $19.9K | Hold |
1,200
| – | – | ﹤0.01% | 585 |
|
|
2022
Q4 | $22.3K | Hold |
1,200
| – | – | ﹤0.01% | 567 |
|
|
2022
Q3 | $15K | Hold |
1,200
| – | – | ﹤0.01% | 611 |
|
|
2022
Q2 | $8K | Hold |
1,200
| – | – | ﹤0.01% | 717 |
|
|
2022
Q1 | $10K | Buy |
+1,200
| New | +$10K | ﹤0.01% | 713 |
|